David Kennedy’s research focuses on investigating how pathogens, including viruses and bacteria, evolve. He is particularly interested in how selection pressures, such as drugs and vaccines, may influence this evolution. This knowledge can be used to delay, prevent, or reverse adverse evolutionary outcomes, such as drug and vaccine resistance.
Will Covid variant omicron need a new vaccine? Time and data will tell
from NBC News November 26, 2021
Vaccine Makers Already Testing Their Shots Against Omicron Variant
from U.S. News and World Report November 29, 2021
How Much Should We Really Worry About the Coronavirus Variants?
from SLATE March 17, 2021
Penn State expertise spans far beyond those that we have currently featured on the site. Call us at 814-865-7517 or contact a member of the media relations staff